The Oncology Institute, Inc. (NASDAQ: TOI) Stock Competitors & Peer Comparison
See TOI's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for TOI and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| TOI | $5.13 | -19.72% | 512.9M | -14.25 | -$0.36 | N/A |
| HCA | $404.68 | -1.71% | 87.6B | 13.97 | $28.96 | +0.74% |
| THC | $267.90 | +0.32% | 21.6B | 15.54 | $17.24 | N/A |
| FMS | $23.77 | +0.59% | 12.8B | 8.93 | $2.66 | +3.64% |
| EHC | $123.59 | +0.03% | 12.3B | 21.16 | $5.84 | +0.61% |
| BTSGU | $203.17 | +1.04% | 12B | 184.06 | $1.11 | N/A |
| DVA | $180.06 | -0.79% | 11.5B | 14.00 | $12.80 | N/A |
| ENSG | $181.65 | -0.13% | 10.6B | 26.33 | $6.90 | +0.14% |
| UHS | $170.02 | -0.70% | 10.3B | 7.54 | $22.54 | +0.47% |
| OSH | $39.00 | +0.08% | 9.5B | -17.65 | -$2.21 | N/A |
Stock Comparison
HCA Healthcare, Inc. (NYSE: HCA)
TOI vs HCA Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, HCA has a market cap of 87.6B. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while HCA trades at $404.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas HCA's P/E ratio is 13.97. In terms of profitability, TOI's ROE is +2.10%, compared to HCA's ROE of -1.13%. Regarding short-term risk, TOI is more volatile compared to HCA. This indicates higher risk in terms of short-term price fluctuations for TOI.Check HCA's competition here
Tenet Healthcare Corporation (NYSE: THC)
TOI vs THC Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, THC has a market cap of 21.6B. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while THC trades at $267.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas THC's P/E ratio is 15.54. In terms of profitability, TOI's ROE is +2.10%, compared to THC's ROE of +0.51%. Regarding short-term risk, TOI is more volatile compared to THC. This indicates higher risk in terms of short-term price fluctuations for TOI.Check THC's competition here
Fresenius Medical Care AG & Co. KGaA (NYSE: FMS)
TOI vs FMS Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, FMS has a market cap of 12.8B. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while FMS trades at $23.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas FMS's P/E ratio is 8.93. In terms of profitability, TOI's ROE is +2.10%, compared to FMS's ROE of +0.07%. Regarding short-term risk, TOI is more volatile compared to FMS. This indicates higher risk in terms of short-term price fluctuations for TOI.Check FMS's competition here
Encompass Health Corporation (NYSE: EHC)
TOI vs EHC Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, EHC has a market cap of 12.3B. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while EHC trades at $123.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas EHC's P/E ratio is 21.16. In terms of profitability, TOI's ROE is +2.10%, compared to EHC's ROE of +0.25%. Regarding short-term risk, TOI is more volatile compared to EHC. This indicates higher risk in terms of short-term price fluctuations for TOI.Check EHC's competition here
BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ: BTSGU)
TOI vs BTSGU Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, BTSGU has a market cap of 12B. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while BTSGU trades at $203.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas BTSGU's P/E ratio is 184.06. In terms of profitability, TOI's ROE is +2.10%, compared to BTSGU's ROE of +0.15%. Regarding short-term risk, TOI is more volatile compared to BTSGU. This indicates higher risk in terms of short-term price fluctuations for TOI.Check BTSGU's competition here
DaVita Inc. (NYSE: DVA)
TOI vs DVA Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, DVA has a market cap of 11.5B. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while DVA trades at $180.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas DVA's P/E ratio is 14.00. In terms of profitability, TOI's ROE is +2.10%, compared to DVA's ROE of -1.24%. Regarding short-term risk, TOI is more volatile compared to DVA. This indicates higher risk in terms of short-term price fluctuations for TOI.Check DVA's competition here
The Ensign Group, Inc. (NASDAQ: ENSG)
TOI vs ENSG Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, ENSG has a market cap of 10.6B. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while ENSG trades at $181.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas ENSG's P/E ratio is 26.33. In terms of profitability, TOI's ROE is +2.10%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, TOI is more volatile compared to ENSG. This indicates higher risk in terms of short-term price fluctuations for TOI.Check ENSG's competition here
Universal Health Services, Inc. (NYSE: UHS)
TOI vs UHS Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, UHS has a market cap of 10.3B. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while UHS trades at $170.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas UHS's P/E ratio is 7.54. In terms of profitability, TOI's ROE is +2.10%, compared to UHS's ROE of +0.21%. Regarding short-term risk, TOI is more volatile compared to UHS. This indicates higher risk in terms of short-term price fluctuations for TOI.Check UHS's competition here
Oak Street Health, Inc. (NYSE: OSH)
TOI vs OSH Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas OSH's P/E ratio is -17.65. In terms of profitability, TOI's ROE is +2.10%, compared to OSH's ROE of +4.64%. Regarding short-term risk, TOI is more volatile compared to OSH. This indicates higher risk in terms of short-term price fluctuations for TOI.Check OSH's competition here
PACS Group, Inc. (NYSE: PACS)
TOI vs PACS Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, PACS has a market cap of 7B. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while PACS trades at $44.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas PACS's P/E ratio is 23.51. In terms of profitability, TOI's ROE is +2.10%, compared to PACS's ROE of +0.27%. Regarding short-term risk, TOI is more volatile compared to PACS. This indicates higher risk in terms of short-term price fluctuations for TOI.Check PACS's competition here
Chemed Corporation (NYSE: CHE)
TOI vs CHE Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, CHE has a market cap of 7B. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while CHE trades at $532.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas CHE's P/E ratio is 24.67. In terms of profitability, TOI's ROE is +2.10%, compared to CHE's ROE of +0.29%. Regarding short-term risk, TOI is more volatile compared to CHE. This indicates higher risk in terms of short-term price fluctuations for TOI.Check CHE's competition here
LHC Group, Inc. (NASDAQ: LHCG)
TOI vs LHCG Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas LHCG's P/E ratio is 82.83. In terms of profitability, TOI's ROE is +2.10%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, TOI is more volatile compared to LHCG. This indicates higher risk in terms of short-term price fluctuations for TOI.Check LHCG's competition here
LifeStance Health Group, Inc. (NASDAQ: LFST)
TOI vs LFST Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, LFST has a market cap of 4.8B. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while LFST trades at $12.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas LFST's P/E ratio is 93.55. In terms of profitability, TOI's ROE is +2.10%, compared to LFST's ROE of +0.03%. Regarding short-term risk, TOI is more volatile compared to LFST. This indicates higher risk in terms of short-term price fluctuations for TOI.Check LFST's competition here
Concentra Group Holdings Parent, Inc. (NYSE: CON)
TOI vs CON Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, CON has a market cap of 4.5B. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while CON trades at $35.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas CON's P/E ratio is 24.59. In terms of profitability, TOI's ROE is +2.10%, compared to CON's ROE of +0.47%. Regarding short-term risk, TOI is more volatile compared to CON. This indicates higher risk in terms of short-term price fluctuations for TOI.Check CON's competition here
Option Care Health, Inc. (NASDAQ: OPCH)
TOI vs OPCH Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, OPCH has a market cap of 3.6B. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while OPCH trades at $23.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas OPCH's P/E ratio is 13.92. In terms of profitability, TOI's ROE is +2.10%, compared to OPCH's ROE of +0.16%. Regarding short-term risk, TOI is more volatile compared to OPCH. This indicates higher risk in terms of short-term price fluctuations for TOI.Check OPCH's competition here
National HealthCare Corporation (AMEX: NHC)
TOI vs NHC Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, NHC has a market cap of 3.5B. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while NHC trades at $223.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas NHC's P/E ratio is 28.34. In terms of profitability, TOI's ROE is +2.10%, compared to NHC's ROE of +0.13%. Regarding short-term risk, TOI is less volatile compared to NHC. This indicates lower risk in terms of short-term price fluctuations for TOI.Check NHC's competition here
Amedisys, Inc. (NASDAQ: AMED)
TOI vs AMED Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, AMED has a market cap of 3.3B. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while AMED trades at $100.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas AMED's P/E ratio is 39.30. In terms of profitability, TOI's ROE is +2.10%, compared to AMED's ROE of +0.11%. Regarding short-term risk, TOI is more volatile compared to AMED. This indicates higher risk in terms of short-term price fluctuations for TOI.Check AMED's competition here
Brookdale Senior Living Inc. (NYSE: BKD)
TOI vs BKD Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, BKD has a market cap of 3B. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while BKD trades at $12.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas BKD's P/E ratio is -21.77. In terms of profitability, TOI's ROE is +2.10%, compared to BKD's ROE of +4.06%. Regarding short-term risk, TOI is more volatile compared to BKD. This indicates higher risk in terms of short-term price fluctuations for TOI.Check BKD's competition here
Acadia Healthcare Company, Inc. (NASDAQ: ACHC)
TOI vs ACHC Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, ACHC has a market cap of 2.9B. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while ACHC trades at $30.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas ACHC's P/E ratio is 15.49. In terms of profitability, TOI's ROE is +2.10%, compared to ACHC's ROE of -0.50%. Regarding short-term risk, TOI is more volatile compared to ACHC. This indicates higher risk in terms of short-term price fluctuations for TOI.Check ACHC's competition here
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH)
TOI vs AVAH Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, AVAH has a market cap of 2.7B. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while AVAH trades at $12.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas AVAH's P/E ratio is 18.12. In terms of profitability, TOI's ROE is +2.10%, compared to AVAH's ROE of +1.50%. Regarding short-term risk, TOI is less volatile compared to AVAH. This indicates lower risk in terms of short-term price fluctuations for TOI.Check AVAH's competition here
Guardian Pharmacy Services, Inc. (NYSE: GRDN)
TOI vs GRDN Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, GRDN has a market cap of 2.4B. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while GRDN trades at $38.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas GRDN's P/E ratio is 33.72. In terms of profitability, TOI's ROE is +2.10%, compared to GRDN's ROE of +0.31%. Regarding short-term risk, TOI is more volatile compared to GRDN. This indicates higher risk in terms of short-term price fluctuations for TOI.Check GRDN's competition here
Pediatrix Medical Group, Inc. (NYSE: MD)
TOI vs MD Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, MD has a market cap of 2.2B. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while MD trades at $26.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas MD's P/E ratio is 11.88. In terms of profitability, TOI's ROE is +2.10%, compared to MD's ROE of +0.20%. Regarding short-term risk, TOI is more volatile compared to MD. This indicates higher risk in terms of short-term price fluctuations for TOI.Check MD's competition here
Addus HomeCare Corporation (NASDAQ: ADUS)
TOI vs ADUS Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, ADUS has a market cap of 2.2B. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while ADUS trades at $116.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas ADUS's P/E ratio is 17.37. In terms of profitability, TOI's ROE is +2.10%, compared to ADUS's ROE of +0.10%. Regarding short-term risk, TOI is more volatile compared to ADUS. This indicates higher risk in terms of short-term price fluctuations for TOI.Check ADUS's competition here
Select Medical Holdings Corporation (NYSE: SEM)
TOI vs SEM Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, SEM has a market cap of 2B. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while SEM trades at $16.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas SEM's P/E ratio is 15.43. In terms of profitability, TOI's ROE is +2.10%, compared to SEM's ROE of +0.08%. Regarding short-term risk, TOI is more volatile compared to SEM. This indicates higher risk in terms of short-term price fluctuations for TOI.Check SEM's competition here
Astrana Health, Inc. (NASDAQ: ASTH)
TOI vs ASTH Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, ASTH has a market cap of 2B. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while ASTH trades at $40.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas ASTH's P/E ratio is 39.24. In terms of profitability, TOI's ROE is +2.10%, compared to ASTH's ROE of +0.05%. Regarding short-term risk, TOI is less volatile compared to ASTH. This indicates lower risk in terms of short-term price fluctuations for TOI.Check ASTH's competition here
Surgery Partners, Inc. (NASDAQ: SGRY)
TOI vs SGRY Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, SGRY has a market cap of 2B. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while SGRY trades at $15.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas SGRY's P/E ratio is 38.54. In terms of profitability, TOI's ROE is +2.10%, compared to SGRY's ROE of -0.05%. Regarding short-term risk, TOI is more volatile compared to SGRY. This indicates higher risk in terms of short-term price fluctuations for TOI.Check SGRY's competition here
Sonida Senior Living, Inc. (NYSE: SNDA)
TOI vs SNDA Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, SNDA has a market cap of 1.9B. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while SNDA trades at $39.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas SNDA's P/E ratio is -7.25. In terms of profitability, TOI's ROE is +2.10%, compared to SNDA's ROE of -0.26%. Regarding short-term risk, TOI is more volatile compared to SNDA. This indicates higher risk in terms of short-term price fluctuations for TOI.Check SNDA's competition here
Apollo Medical Holdings, Inc. (NASDAQ: AMEH)
TOI vs AMEH Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas AMEH's P/E ratio is 39.25. In terms of profitability, TOI's ROE is +2.10%, compared to AMEH's ROE of +0.05%. Regarding short-term risk, TOI is more volatile compared to AMEH. This indicates higher risk in terms of short-term price fluctuations for TOI.Check AMEH's competition here
Agilon Health, Inc. (NYSE: AGL)
TOI vs AGL Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, AGL has a market cap of 1.6B. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while AGL trades at $96.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas AGL's P/E ratio is -10.83. In terms of profitability, TOI's ROE is +2.10%, compared to AGL's ROE of -1.19%. Regarding short-term risk, TOI is less volatile compared to AGL. This indicates lower risk in terms of short-term price fluctuations for TOI.Check AGL's competition here
Ardent Health Inc. (NYSE: ARDT)
TOI vs ARDT Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, ARDT has a market cap of 1.6B. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while ARDT trades at $10.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas ARDT's P/E ratio is 8.81. In terms of profitability, TOI's ROE is +2.10%, compared to ARDT's ROE of +0.05%. Regarding short-term risk, TOI is more volatile compared to ARDT. This indicates higher risk in terms of short-term price fluctuations for TOI.Check ARDT's competition here
Healthcare Services Group, Inc. (NASDAQ: HCSG)
TOI vs HCSG Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, HCSG has a market cap of 1.5B. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while HCSG trades at $21.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas HCSG's P/E ratio is 17.27. In terms of profitability, TOI's ROE is +2.10%, compared to HCSG's ROE of +0.24%. Regarding short-term risk, TOI is more volatile compared to HCSG. This indicates higher risk in terms of short-term price fluctuations for TOI.Check HCSG's competition here
Innovage Holding Corp. (NASDAQ: INNV)
TOI vs INNV Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, INNV has a market cap of 1.4B. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while INNV trades at $10.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas INNV's P/E ratio is -117.89. In terms of profitability, TOI's ROE is +2.10%, compared to INNV's ROE of -0.09%. Regarding short-term risk, TOI is more volatile compared to INNV. This indicates higher risk in terms of short-term price fluctuations for TOI.Check INNV's competition here
The Pennant Group, Inc. (NASDAQ: PNTG)
TOI vs PNTG Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, PNTG has a market cap of 1.4B. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while PNTG trades at $39.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas PNTG's P/E ratio is 29.79. In terms of profitability, TOI's ROE is +2.10%, compared to PNTG's ROE of +0.10%. Regarding short-term risk, TOI is more volatile compared to PNTG. This indicates higher risk in terms of short-term price fluctuations for TOI.Check PNTG's competition here
AMN Healthcare Services, Inc. (NYSE: AMN)
TOI vs AMN Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, AMN has a market cap of 1.3B. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while AMN trades at $34.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas AMN's P/E ratio is 11.44. In terms of profitability, TOI's ROE is +2.10%, compared to AMN's ROE of +0.15%. Regarding short-term risk, TOI is more volatile compared to AMN. This indicates higher risk in terms of short-term price fluctuations for TOI.Check AMN's competition here
Nutex Health, Inc. (NASDAQ: NUTX)
TOI vs NUTX Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, NUTX has a market cap of 1.3B. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while NUTX trades at $187.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas NUTX's P/E ratio is 14.48. In terms of profitability, TOI's ROE is +2.10%, compared to NUTX's ROE of +0.52%. Regarding short-term risk, TOI is less volatile compared to NUTX. This indicates lower risk in terms of short-term price fluctuations for TOI.Check NUTX's competition here
U.S. Physical Therapy, Inc. (NYSE: USPH)
TOI vs USPH Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, USPH has a market cap of 1.2B. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while USPH trades at $81.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas USPH's P/E ratio is 31.94. In terms of profitability, TOI's ROE is +2.10%, compared to USPH's ROE of +0.00%. Regarding short-term risk, TOI is more volatile compared to USPH. This indicates higher risk in terms of short-term price fluctuations for TOI.Check USPH's competition here
Brookdale Senior Living Inc. 7. (NYSE: BKDT)
TOI vs BKDT Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas BKDT's P/E ratio is N/A. In terms of profitability, TOI's ROE is +2.10%, compared to BKDT's ROE of +4.06%. Regarding short-term risk, TOI is more volatile compared to BKDT. This indicates higher risk in terms of short-term price fluctuations for TOI.Check BKDT's competition here
Talkspace, Inc. (NASDAQ: TALK)
TOI vs TALK Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, TALK has a market cap of 879.4M. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while TALK trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas TALK's P/E ratio is 774.34. In terms of profitability, TOI's ROE is +2.10%, compared to TALK's ROE of +0.00%. Regarding short-term risk, TOI is more volatile compared to TALK. This indicates higher risk in terms of short-term price fluctuations for TOI.Check TALK's competition here
Fidelity Select Health Care Svcs Port (NASDAQ: FSHCX)
TOI vs FSHCX Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, FSHCX has a market cap of 877.3M. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while FSHCX trades at $116.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas FSHCX's P/E ratio is N/A. In terms of profitability, TOI's ROE is +2.10%, compared to FSHCX's ROE of N/A. Regarding short-term risk, TOI is more volatile compared to FSHCX. This indicates higher risk in terms of short-term price fluctuations for TOI.Check FSHCX's competition here
GMR Solutions Inc. (NYSE: GMRS)
TOI vs GMRS Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, GMRS has a market cap of 718.9M. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while GMRS trades at $13.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas GMRS's P/E ratio is 5.92. In terms of profitability, TOI's ROE is +2.10%, compared to GMRS's ROE of +0.16%. Regarding short-term risk, TOI is less volatile compared to GMRS. This indicates lower risk in terms of short-term price fluctuations for TOI.Check GMRS's competition here
Enhabit, Inc. (NYSE: EHAB)
TOI vs EHAB Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, EHAB has a market cap of 706.9M. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while EHAB trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas EHAB's P/E ratio is -197.14. In terms of profitability, TOI's ROE is +2.10%, compared to EHAB's ROE of -0.01%. Regarding short-term risk, TOI is more volatile compared to EHAB. This indicates higher risk in terms of short-term price fluctuations for TOI.Check EHAB's competition here
Starling Oncology, Inc. (NASDAQ: STLN)
TOI vs STLN Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, STLN has a market cap of 644.9M. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while STLN trades at $6.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas STLN's P/E ratio is N/A. In terms of profitability, TOI's ROE is +2.10%, compared to STLN's ROE of +2.10%. Regarding short-term risk, TOI is less volatile compared to STLN. This indicates lower risk in terms of short-term price fluctuations for TOI.Check STLN's competition here
Strata Critical Medical, Inc. (NASDAQ: SRTA)
TOI vs SRTA Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, SRTA has a market cap of 510.5M. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while SRTA trades at $5.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas SRTA's P/E ratio is -27.81. In terms of profitability, TOI's ROE is +2.10%, compared to SRTA's ROE of +0.14%. Regarding short-term risk, TOI is more volatile compared to SRTA. This indicates higher risk in terms of short-term price fluctuations for TOI.Check SRTA's competition here
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA)
TOI vs MCTA Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, MCTA has a market cap of 445.6M. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while MCTA trades at $29.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas MCTA's P/E ratio is 419.36. In terms of profitability, TOI's ROE is +2.10%, compared to MCTA's ROE of -2.33%. Regarding short-term risk, TOI is more volatile compared to MCTA. This indicates higher risk in terms of short-term price fluctuations for TOI.Check MCTA's competition here
Community Health Systems, Inc. (NYSE: CYH)
TOI vs CYH Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, CYH has a market cap of 419.5M. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while CYH trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas CYH's P/E ratio is 4.08. In terms of profitability, TOI's ROE is +2.10%, compared to CYH's ROE of +0.21%. Regarding short-term risk, TOI is more volatile compared to CYH. This indicates higher risk in terms of short-term price fluctuations for TOI.Check CYH's competition here
Auna S.A. (NYSE: AUNA)
TOI vs AUNA Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, AUNA has a market cap of 388.6M. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while AUNA trades at $5.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas AUNA's P/E ratio is 4.73. In terms of profitability, TOI's ROE is +2.10%, compared to AUNA's ROE of +0.04%. Regarding short-term risk, TOI is more volatile compared to AUNA. This indicates higher risk in terms of short-term price fluctuations for TOI.Check AUNA's competition here
Viemed Healthcare, Inc. (NASDAQ: VMD)
TOI vs VMD Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, VMD has a market cap of 350.4M. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while VMD trades at $9.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas VMD's P/E ratio is 25.56. In terms of profitability, TOI's ROE is +2.10%, compared to VMD's ROE of +0.10%. Regarding short-term risk, TOI is more volatile compared to VMD. This indicates higher risk in terms of short-term price fluctuations for TOI.Check VMD's competition here
AirSculpt Technologies, Inc. (NASDAQ: AIRS)
TOI vs AIRS Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, AIRS has a market cap of 242M. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while AIRS trades at $3.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas AIRS's P/E ratio is -114.33. In terms of profitability, TOI's ROE is +2.10%, compared to AIRS's ROE of -0.13%. Regarding short-term risk, TOI is more volatile compared to AIRS. This indicates higher risk in terms of short-term price fluctuations for TOI.Check AIRS's competition here
Capital Senior Living Corporation (NYSE: CSU)
TOI vs CSU Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas CSU's P/E ratio is 0.67. In terms of profitability, TOI's ROE is +2.10%, compared to CSU's ROE of -0.33%. Regarding short-term risk, TOI is more volatile compared to CSU. This indicates higher risk in terms of short-term price fluctuations for TOI.Check CSU's competition here
The Joint Corp. (NASDAQ: JYNT)
TOI vs JYNT Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, JYNT has a market cap of 120.5M. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while JYNT trades at $8.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas JYNT's P/E ratio is 84.50. In terms of profitability, TOI's ROE is +2.10%, compared to JYNT's ROE of +0.22%. Regarding short-term risk, TOI is more volatile compared to JYNT. This indicates higher risk in terms of short-term price fluctuations for TOI.Check JYNT's competition here
Park Dental Partners, Inc. Common Stock (NASDAQ: PARK)
TOI vs PARK Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, PARK has a market cap of 103.9M. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while PARK trades at $22.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas PARK's P/E ratio is 31.11. In terms of profitability, TOI's ROE is +2.10%, compared to PARK's ROE of -0.00%. Regarding short-term risk, TOI is less volatile compared to PARK. This indicates lower risk in terms of short-term price fluctuations for TOI.Check PARK's competition here
Five Star Senior Living Inc. (NASDAQ: FVE)
TOI vs FVE Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas FVE's P/E ratio is -5.64. In terms of profitability, TOI's ROE is +2.10%, compared to FVE's ROE of -0.15%. Regarding short-term risk, TOI is more volatile compared to FVE. This indicates higher risk in terms of short-term price fluctuations for TOI.Check FVE's competition here
Kindly MD, Inc. (NASDAQ: KDLYW)
TOI vs KDLYW Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while KDLYW trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas KDLYW's P/E ratio is N/A. In terms of profitability, TOI's ROE is +2.10%, compared to KDLYW's ROE of -1.05%. Regarding short-term risk, TOI is less volatile compared to KDLYW. This indicates lower risk in terms of short-term price fluctuations for TOI.Check KDLYW's competition here
biote Corp. (NASDAQ: BTMD)
TOI vs BTMD Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, BTMD has a market cap of 64.8M. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while BTMD trades at $1.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas BTMD's P/E ratio is 13.36. In terms of profitability, TOI's ROE is +2.10%, compared to BTMD's ROE of -0.09%. Regarding short-term risk, TOI is more volatile compared to BTMD. This indicates higher risk in terms of short-term price fluctuations for TOI.Check BTMD's competition here
DocGo Inc. (NASDAQ: DCGO)
TOI vs DCGO Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, DCGO has a market cap of 64.5M. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while DCGO trades at $0.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas DCGO's P/E ratio is -0.75. In terms of profitability, TOI's ROE is +2.10%, compared to DCGO's ROE of -0.89%. Regarding short-term risk, TOI is more volatile compared to DCGO. This indicates higher risk in terms of short-term price fluctuations for TOI.Check DCGO's competition here
AlerisLife Inc. (NASDAQ: ALR)
TOI vs ALR Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas ALR's P/E ratio is -1.11. In terms of profitability, TOI's ROE is +2.10%, compared to ALR's ROE of -0.15%. Regarding short-term risk, TOI is more volatile compared to ALR. This indicates higher risk in terms of short-term price fluctuations for TOI.Check ALR's competition here
P3 Health Partners Inc. (NASDAQ: PIII)
TOI vs PIII Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, PIII has a market cap of 35M. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while PIII trades at $10.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas PIII's P/E ratio is -0.27. In terms of profitability, TOI's ROE is +2.10%, compared to PIII's ROE of +1.61%. Regarding short-term risk, TOI is more volatile compared to PIII. This indicates higher risk in terms of short-term price fluctuations for TOI.Check PIII's competition here
IMAC Holdings, Inc. (NASDAQ: IMAC)
TOI vs IMAC Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas IMAC's P/E ratio is -2.27. In terms of profitability, TOI's ROE is +2.10%, compared to IMAC's ROE of +0.00%. Regarding short-term risk, TOI is more volatile compared to IMAC. This indicates higher risk in terms of short-term price fluctuations for TOI.Check IMAC's competition here
Cryo-Cell International, Inc. (AMEX: CCEL)
TOI vs CCEL Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, CCEL has a market cap of 32.3M. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while CCEL trades at $3.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas CCEL's P/E ratio is -13.33. In terms of profitability, TOI's ROE is +2.10%, compared to CCEL's ROE of +0.14%. Regarding short-term risk, TOI is more volatile compared to CCEL. This indicates higher risk in terms of short-term price fluctuations for TOI.Check CCEL's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
TOI vs EUDA Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, EUDA has a market cap of 26.4M. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while EUDA trades at $14.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas EUDA's P/E ratio is -26.63. In terms of profitability, TOI's ROE is +2.10%, compared to EUDA's ROE of +1.20%. Regarding short-term risk, TOI is more volatile compared to EUDA. This indicates higher risk in terms of short-term price fluctuations for TOI.Check EUDA's competition here
Cano Health, Inc. (NYSE: CANO-WT)
TOI vs CANO-WT Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, CANO-WT has a market cap of 19.3M. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while CANO-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas CANO-WT's P/E ratio is N/A. In terms of profitability, TOI's ROE is +2.10%, compared to CANO-WT's ROE of -1.49%. Regarding short-term risk, TOI is less volatile compared to CANO-WT. This indicates lower risk in terms of short-term price fluctuations for TOI.Check CANO-WT's competition here
Aesthetic Medical International Holdings Group Limited (NASDAQ: AIH)
TOI vs AIH Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas AIH's P/E ratio is -2.78. In terms of profitability, TOI's ROE is +2.10%, compared to AIH's ROE of +1.16%. Regarding short-term risk, TOI is less volatile compared to AIH. This indicates lower risk in terms of short-term price fluctuations for TOI.Check AIH's competition here
Cano Health, Inc. (NYSE: CANO)
TOI vs CANO Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas CANO's P/E ratio is -0.01. In terms of profitability, TOI's ROE is +2.10%, compared to CANO's ROE of -1.49%. Regarding short-term risk, TOI is less volatile compared to CANO. This indicates lower risk in terms of short-term price fluctuations for TOI.Check CANO's competition here
Avem Health Partners, Inc. (NYSE: FPCG)
TOI vs FPCG Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, FPCG has a market cap of 10.1M. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas FPCG's P/E ratio is 0.09. In terms of profitability, TOI's ROE is +2.10%, compared to FPCG's ROE of +0.00%. Regarding short-term risk, TOI is more volatile compared to FPCG. This indicates higher risk in terms of short-term price fluctuations for TOI.Check FPCG's competition here
American Shared Hospital Services (AMEX: AMS)
TOI vs AMS Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, AMS has a market cap of 9.9M. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while AMS trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas AMS's P/E ratio is -6.74. In terms of profitability, TOI's ROE is +2.10%, compared to AMS's ROE of -0.07%. Regarding short-term risk, TOI is less volatile compared to AMS. This indicates lower risk in terms of short-term price fluctuations for TOI.Check AMS's competition here
Field Trip Health Ltd. (NASDAQ: FTRP)
TOI vs FTRP Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas FTRP's P/E ratio is -1.22. In terms of profitability, TOI's ROE is +2.10%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, TOI is more volatile compared to FTRP. This indicates higher risk in terms of short-term price fluctuations for TOI.Check FTRP's competition here
Basel Medical Group Ltd Ordinary Shares (NASDAQ: BMGL)
TOI vs BMGL Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, BMGL has a market cap of 8.6M. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while BMGL trades at $5.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas BMGL's P/E ratio is -1.04. In terms of profitability, TOI's ROE is +2.10%, compared to BMGL's ROE of -1.74%. Regarding short-term risk, TOI is less volatile compared to BMGL. This indicates lower risk in terms of short-term price fluctuations for TOI.Check BMGL's competition here
XWELL, Inc. (NASDAQ: XWEL)
TOI vs XWEL Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, XWEL has a market cap of 7.9M. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while XWEL trades at $0.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas XWEL's P/E ratio is -0.18. In terms of profitability, TOI's ROE is +2.10%, compared to XWEL's ROE of +2.89%. Regarding short-term risk, TOI is more volatile compared to XWEL. This indicates higher risk in terms of short-term price fluctuations for TOI.Check XWEL's competition here
20/20 Biolabs Inc. (NASDAQ: AIDX)
TOI vs AIDX Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, AIDX has a market cap of 6.7M. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while AIDX trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas AIDX's P/E ratio is -1.04. In terms of profitability, TOI's ROE is +2.10%, compared to AIDX's ROE of +0.79%. Regarding short-term risk, TOI is less volatile compared to AIDX. This indicates lower risk in terms of short-term price fluctuations for TOI.Check AIDX's competition here
ModivCare Inc. (NASDAQ: MODV)
TOI vs MODV Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, MODV has a market cap of 6.2M. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while MODV trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas MODV's P/E ratio is -0.06. In terms of profitability, TOI's ROE is +2.10%, compared to MODV's ROE of +1.36%. Regarding short-term risk, TOI is more volatile compared to MODV. This indicates higher risk in terms of short-term price fluctuations for TOI.Check MODV's competition here
Greenbrook TMS Inc. (NASDAQ: GBNH)
TOI vs GBNH Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas GBNH's P/E ratio is -0.06. In terms of profitability, TOI's ROE is +2.10%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, TOI is less volatile compared to GBNH. This indicates lower risk in terms of short-term price fluctuations for TOI.Check GBNH's competition here
Regional Health Properties, Inc. (AMEX: RHE)
TOI vs RHE Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas RHE's P/E ratio is -1.79. In terms of profitability, TOI's ROE is +2.10%, compared to RHE's ROE of -1.31%. Regarding short-term risk, TOI is less volatile compared to RHE. This indicates lower risk in terms of short-term price fluctuations for TOI.Check RHE's competition here
Regional Health Properties, Inc. (AMEX: RHE-PA)
TOI vs RHE-PA Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, RHE-PA has a market cap of 5.2M. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, TOI's ROE is +2.10%, compared to RHE-PA's ROE of +1.09%. Regarding short-term risk, TOI is less volatile compared to RHE-PA. This indicates lower risk in terms of short-term price fluctuations for TOI.Check RHE-PA's competition here
Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst (NASDAQ: STLNW)
TOI vs STLNW Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, STLNW has a market cap of 5M. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while STLNW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas STLNW's P/E ratio is N/A. In terms of profitability, TOI's ROE is +2.10%, compared to STLNW's ROE of N/A. Regarding short-term risk, TOI is less volatile compared to STLNW. This indicates lower risk in terms of short-term price fluctuations for TOI.Check STLNW's competition here
The Oncology Institute, Inc. (NASDAQ: TOIIW)
TOI vs TOIIW Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, TOIIW has a market cap of 4.7M. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while TOIIW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas TOIIW's P/E ratio is -0.17. In terms of profitability, TOI's ROE is +2.10%, compared to TOIIW's ROE of +2.10%. Regarding short-term risk, TOI is more volatile compared to TOIIW. This indicates higher risk in terms of short-term price fluctuations for TOI.Check TOIIW's competition here
IMAC Holdings, Inc. (NASDAQ: IMACW)
TOI vs IMACW Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas IMACW's P/E ratio is N/A. In terms of profitability, TOI's ROE is +2.10%, compared to IMACW's ROE of +0.73%. Regarding short-term risk, TOI is less volatile compared to IMACW. This indicates lower risk in terms of short-term price fluctuations for TOI.Check IMACW's competition here
Nakamoto Inc. (NASDAQ: NAKAW)
TOI vs NAKAW Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, NAKAW has a market cap of 1.5M. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while NAKAW trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas NAKAW's P/E ratio is -0.53. In terms of profitability, TOI's ROE is +2.10%, compared to NAKAW's ROE of -1.05%. Regarding short-term risk, TOI is more volatile compared to NAKAW. This indicates higher risk in terms of short-term price fluctuations for TOI.Check NAKAW's competition here
Concord Medical Services Holdings Limited (NYSE: CCM)
TOI vs CCM Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, CCM has a market cap of 690.2K. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while CCM trades at $4.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas CCM's P/E ratio is -0.32. In terms of profitability, TOI's ROE is +2.10%, compared to CCM's ROE of +0.06%. Regarding short-term risk, TOI is less volatile compared to CCM. This indicates lower risk in terms of short-term price fluctuations for TOI.Check CCM's competition here
NewGenIvf Group Limited (NASDAQ: NIVF)
TOI vs NIVF Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, NIVF has a market cap of 109.4K. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while NIVF trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas NIVF's P/E ratio is 0.28. In terms of profitability, TOI's ROE is +2.10%, compared to NIVF's ROE of +0.33%. Regarding short-term risk, TOI is less volatile compared to NIVF. This indicates lower risk in terms of short-term price fluctuations for TOI.Check NIVF's competition here
Mobile-health Network Solutions Class A Ordinary Shares (NASDAQ: MNDR)
TOI vs MNDR Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, MNDR has a market cap of 42.3K. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while MNDR trades at $1.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas MNDR's P/E ratio is -0.04. In terms of profitability, TOI's ROE is +2.10%, compared to MNDR's ROE of -0.46%. Regarding short-term risk, TOI is less volatile compared to MNDR. This indicates lower risk in terms of short-term price fluctuations for TOI.Check MNDR's competition here
NewGenIvf Group Limited (NASDAQ: NIVFW)
TOI vs NIVFW Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, NIVFW has a market cap of 39.8K. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while NIVFW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas NIVFW's P/E ratio is -0.01. In terms of profitability, TOI's ROE is +2.10%, compared to NIVFW's ROE of +0.33%. Regarding short-term risk, TOI is more volatile compared to NIVFW. This indicates higher risk in terms of short-term price fluctuations for TOI.Check NIVFW's competition here
Talkspace, Inc. (NASDAQ: TALKW)
TOI vs TALKW Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, TALKW has a market cap of 33.5K. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while TALKW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas TALKW's P/E ratio is 0.00. In terms of profitability, TOI's ROE is +2.10%, compared to TALKW's ROE of +0.00%. Regarding short-term risk, TOI is less volatile compared to TALKW. This indicates lower risk in terms of short-term price fluctuations for TOI.Check TALKW's competition here
SOC Telemed, Inc. (NASDAQ: TLMD)
TOI vs TLMD Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, TLMD has a market cap of 0. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while TLMD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas TLMD's P/E ratio is -1.60. In terms of profitability, TOI's ROE is +2.10%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, TOI is more volatile compared to TLMD. This indicates higher risk in terms of short-term price fluctuations for TOI.Check TLMD's competition here
Kindred Healthcare, Inc. (NYSE: KND)
TOI vs KND Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, KND has a market cap of 0. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while KND trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas KND's P/E ratio is -1.14. In terms of profitability, TOI's ROE is +2.10%, compared to KND's ROE of -0.53%. Regarding short-term risk, TOI is more volatile compared to KND. This indicates higher risk in terms of short-term price fluctuations for TOI.Check KND's competition here
Skylight Health Group Inc. (NASDAQ: SLHGP)
TOI vs SLHGP Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while SLHGP trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, TOI's ROE is +2.10%, compared to SLHGP's ROE of -0.48%. Regarding short-term risk, TOI is more volatile compared to SLHGP. This indicates higher risk in terms of short-term price fluctuations for TOI.Check SLHGP's competition here
New Frontier Health Corporation (NYSE: NFH)
TOI vs NFH Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, NFH has a market cap of 0. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while NFH trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas NFH's P/E ratio is -19.75. In terms of profitability, TOI's ROE is +2.10%, compared to NFH's ROE of -0.06%. Regarding short-term risk, TOI is more volatile compared to NFH. This indicates higher risk in terms of short-term price fluctuations for TOI.Check NFH's competition here
DocGo Inc. (NASDAQ: DCGOW)
TOI vs DCGOW Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while DCGOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas DCGOW's P/E ratio is N/A. In terms of profitability, TOI's ROE is +2.10%, compared to DCGOW's ROE of -0.89%. Regarding short-term risk, TOI is less volatile compared to DCGOW. This indicates lower risk in terms of short-term price fluctuations for TOI.Check DCGOW's competition here
Tivity Health, Inc. (NASDAQ: TVTY)
TOI vs TVTY Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, TVTY has a market cap of 0. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while TVTY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas TVTY's P/E ratio is 19.06. In terms of profitability, TOI's ROE is +2.10%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, TOI is more volatile compared to TVTY. This indicates higher risk in terms of short-term price fluctuations for TOI.Check TVTY's competition here
SOC Telemed, Inc. (NASDAQ: TLMDW)
TOI vs TLMDW Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while TLMDW trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas TLMDW's P/E ratio is N/A. In terms of profitability, TOI's ROE is +2.10%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, TOI is more volatile compared to TLMDW. This indicates higher risk in terms of short-term price fluctuations for TOI.Check TLMDW's competition here
Hanger, Inc. (NYSE: HNGR)
TOI vs HNGR Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, HNGR has a market cap of 0. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while HNGR trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas HNGR's P/E ratio is 19.71. In terms of profitability, TOI's ROE is +2.10%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, TOI is more volatile compared to HNGR. This indicates higher risk in terms of short-term price fluctuations for TOI.Check HNGR's competition here
Diversicare Healthcare Services, Inc. (NASDAQ: DVCR)
TOI vs DVCR Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, DVCR has a market cap of 0. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while DVCR trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas DVCR's P/E ratio is 28.34. In terms of profitability, TOI's ROE is +2.10%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, TOI is more volatile compared to DVCR. This indicates higher risk in terms of short-term price fluctuations for TOI.Check DVCR's competition here
ATI Physical Therapy, Inc. (NYSE: ATIP-WT)
TOI vs ATIP-WT Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, ATIP-WT has a market cap of 0. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while ATIP-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas ATIP-WT's P/E ratio is N/A. In terms of profitability, TOI's ROE is +2.10%, compared to ATIP-WT's ROE of +2.05%. Regarding short-term risk, TOI is less volatile compared to ATIP-WT. This indicates lower risk in terms of short-term price fluctuations for TOI.Check ATIP-WT's competition here
Skylight Health Group Inc. (NASDAQ: SLHG)
TOI vs SLHG Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, SLHG has a market cap of 0. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while SLHG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas SLHG's P/E ratio is -1.48. In terms of profitability, TOI's ROE is +2.10%, compared to SLHG's ROE of N/A. Regarding short-term risk, TOI is less volatile compared to SLHG. This indicates lower risk in terms of short-term price fluctuations for TOI.Check SLHG's competition here
Almost Family Inc. (NASDAQ: AFAM)
TOI vs AFAM Comparison August 2026
The Oncology Institute, Inc. (NASDAQ: TOI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TOI stands at 512.9M. In comparison, AFAM has a market cap of 0. Regarding current trading prices, TOI is priced at $5.13 on the NASDAQ, while AFAM trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TOI currently has a P/E ratio of -14.25, whereas AFAM's P/E ratio is N/A. In terms of profitability, TOI's ROE is +2.10%, compared to AFAM's ROE of +0.06%. Regarding short-term risk, TOI is more volatile compared to AFAM. This indicates higher risk in terms of short-term price fluctuations for TOI.Check AFAM's competition here